What are the recommended sumatriptan dosing guidelines for acute migraine treatment in adults and adolescents, including oral, subcutaneous, and nasal spray formulations, and what precautions are needed for elderly patients, those with hepatic impairment, or those taking monoamine‑oxidase inhibitors?

Sumatriptan Dosing for Acute Migraine

For adults with acute moderate-to-severe migraine, start with oral sumatriptan 50 mg combined with an NSAID (or acetaminophen if NSAIDs are contraindicated), taken as early as possible in the attack; if inadequate response after 2 hours, a second 50-100 mg dose may be taken, not exceeding 200 mg total daily. 1, 2

Adult Dosing by Formulation

Oral Sumatriptan

• Starting dose: 50 mg is optimal, balancing efficacy and tolerability 2, 3
• Alternative doses: 25 mg (less effective but better tolerated) or 100 mg (similar efficacy to 50 mg but more adverse events) 2
• Redosing: If headache returns or partial response occurs, repeat after 2 hours minimum
• Maximum daily dose: 200 mg 2
• Always combine with NSAID or acetaminophen for superior efficacy 1

Subcutaneous Sumatriptan

• Dose: 6 mg 4
• Most efficacious formulation (NNT 2.0 at 1 hour vs. 3.0 for oral at 2 hours) 4
• Fastest onset of action 4
• Higher adverse event rate (NNT 3.0 for adverse events) 4
• Use when: Severe nausea/vomiting present, rapid relief needed, or oral route fails 1

Intranasal Sumatriptan

• Dose: 20 mg (10 mg alternative) 5, 6
• Similar efficacy to oral (NNT 3.1 at 2 hours) 4
• Faster onset than oral but limited effect in first 30 minutes 4
• Cmax achieved at 1-1.75 hours 6
• Taste disturbance is most common adverse event 5, 7

Special Populations

Hepatic Impairment

• Maximum single dose: 50 mg oral 8, 2
• Bioavailability increases ~70% with hepatic impairment due to reduced first-pass metabolism 2
• Severe hepatic impairment: CONTRAINDICATED 8

Elderly Patients (≥65 years)

• Start at low end of dosing range (25-50 mg oral) 8
• Mandatory cardiovascular evaluation before prescribing if other cardiovascular risk factors present (diabetes, hypertension, smoking, obesity, strong family history of CAD) 8
• Pharmacokinetics similar to younger adults, but greater frequency of comorbidities requires caution 2

Adolescents (12-17 years)

• Intranasal formulation: 10-20 mg is well-tolerated and effective 9, 5
• Oral sumatriptan has NOT established efficacy in controlled trials for adolescents 8
• Consider sumatriptan/naproxen combination, zolmitriptan nasal, or rizatriptan ODT as alternatives 9
• Pharmacokinetics in adolescents similar to adults 6

Pediatric (<12 years)

• NOT recommended - safety and effectiveness not established 8

Critical Drug Interactions

MAO-A Inhibitors

• CONTRAINDICATED with MAO-A inhibitors 8, 2
• MAO-A inhibitors cause 7-fold increase in oral sumatriptan exposure and 2-fold increase with subcutaneous 2
• Mechanism: Decreased clearance due to inhibited metabolism 2

MAO-B Inhibitors

• No significant interaction - safe to use together 2

Clinical Algorithm

1. First-line: Oral sumatriptan 50 mg + NSAID (naproxen 500 mg preferred) at migraine onset 1

2. If inadequate response to first-line:

   • Increase to 100 mg oral + NSAID 2
   • Try different triptan (individual response varies within class) 1

3. If severe nausea/vomiting:

   • Switch to subcutaneous 6 mg or intranasal 20 mg 1
   • Add antiemetic 1

4. If rapid pain escalation:

   • Use subcutaneous 6 mg (fastest onset) 4

5. Redosing parameters:

   • Minimum 2-hour interval between doses 2
   • Maximum 200 mg oral daily 2
   • Requires 24-hour headache-free period between treated attacks 5

Critical Precautions

Medication Overuse Headache

• Triptan threshold: ≥10 days/month (vs. ≥15 days/month for NSAIDs) 1
• If treating >4 headaches per 30 days, consider preventive therapy 2

Pregnancy and Lactation

• Pregnancy Category C - use only if benefit justifies risk 8
• Breastfeeding: Avoid for 12 hours after dose to minimize infant exposure 8
• Discuss teratogenic risks with patients of childbearing potential 1

Cardiovascular Considerations

• Evaluate cardiovascular risk before prescribing in elderly or those with risk factors 8
• Rare but serious events (MI, stroke) reported, including in 14-year-old 8

Common Pitfalls to Avoid

• Don't use 25 mg as routine starting dose - less effective than 50 mg 2, 3
• Don't prescribe triptan alone - combination with NSAID/acetaminophen superior 1
• Don't delay treatment - early administration improves efficacy 1
• Don't use opioids or butalbital - explicitly not recommended 1
• Don't exceed frequency thresholds - monitor for medication overuse headache 1